PD01: Kidney Cancer: Basic Research & Pathophysiology I

Podium Session Moderator(s)

• PC

  Peter Clark, MD

  Professor and Chair
  Atrium Health and Levine Cancer Institute
• AH

  A. Hakimi, MD
• 

  Shreyas Joshi, MD

  Fox Chase Cancer Center, Temple Health

Presentations:

• 7:00 AM – 7:10 AM

  PD01-01: VHL-mediated ubiquitination of the kinase Mps1 regulates the mitotic checkpoint in clear cell renal cell carcinoma
  
• 7:10 AM – 7:20 AM

  PD01-02: Citrate Transporter – A Potential Tumor Suppressor And Biomarker In Renal Cell Carcinoma
  

  Podium Presenter: Andre Jordan
• 7:20 AM – 7:30 AM

  PD01-03: Alanine–serine–cysteine transporter 2 in glutamine metabolism is a therapeutic target for renal cell carcinoma
  

  Podium Presenter: Yoshinari Muto, MD – Fujita Health University
• 7:30 AM – 7:40 AM

  PD01-04: Glutamine blockade induces cellular senescence in renal cell carcinoma by targeting SLC1A5
  

  Podium Presenter: Issei Kawakami
• 7:40 AM – 7:50 AM

  PD01-05: MiR-182-5p Inhibits the Tumorigenesis of clear cell renal cell carcinoma by Repressing UBE2T
  

  Podium Presenter: Wu Yucai
• 7:50 AM – 8:00 AM

  PD01-06: GCN5L1 Regulates Mitochondrial Acetylation, Lipid Accumulation and Cell Growth in VHL-deficient Clear Cell Renal Cell Carcinoma
  

  Podium Presenter: Bradley Webster, MD, PHD
• 8:00 AM – 8:10 AM

  PD01-07: The Tumor Suppressor FLCN Regulates the Warburg Effect in Renal Cell Carcinoma through Inhibition of Lactate Dehydrogenase-A
  

  Podium Presenter: Rebecca A. Sager, MD, PHD
• 8:10 AM – 8:20 AM

  PD01-08: Comparison of Mutational Profile of Primary versus Organ-specific Metastatic Tumors in Clear Cell Renal Cell Carcinoma
  

  Podium Presenter: Sari S. Khaleel, MD, MSC – Memorial Sloan Kettering Cancer Center
• 8:20 AM – 8:30 AM

  PD01-09: Proteogenomic and clinical implications of recurrent splice variants in clear cell renal cell carcinoma
  

  Podium Presenter: Andrew Chang, MD,Phd – H. Lee Moffitt Cancer Center
• 8:30 AM – 8:40 AM

  PD01-10: Whole Transcriptome Sequencing of Clear Cell Renal Cell Carcinoma Reveals a Multigene Expression Prognostic Signature
  

  Podium Presenter: Simpa Samuel Salami, MD, MPH – University of Michigan, Michigan Medicine
• 8:40 AM – 8:50 AM

  PD01-11: Characterization of Wilms Tumor and Human Fetal Kidney Using Spatial Transcriptomics
  

  Podium Presenter: Laura Perin, PhD
• 8:50 AM – 9:00 AM

  PD01-12: Pan-Cancer Characterization of the Tumor Microenvironment Reveals Stroma and Immune Enriched Subtype with distinct molecular, clinical, and prognostic features in different genitourinary cancers
  

  Podium Presenter: Mark Farha, BS